NPI 1295792893: Open Payments
NPI 1295792893. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$178 in 7 payments from 2 companies in 2025. Trend: 2023 $137 · 2024 $243 · 2025 $178
Food & beverage: $178
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $150 |
| ABBVIE INC. | 1 | $28 |
Products named: CAPLYTA, VRAYLAR.
